LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 85 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,871,000 | -4.5% | 326,300 | 0.0% | 0.04% | +2.7% |
| Q2 2019 | $3,005,000 | +19.1% | 326,300 | -16.8% | 0.04% | +15.6% |
| Q1 2019 | $2,523,000 | -31.8% | 392,300 | 0.0% | 0.03% | -43.9% |
| Q4 2018 | $3,699,000 | -53.2% | 392,300 | 0.0% | 0.06% | -45.7% |
| Q3 2018 | $7,897,000 | -21.6% | 392,300 | +13.6% | 0.10% | -34.0% |
| Q2 2018 | $10,073,000 | -2.8% | 345,300 | -0.8% | 0.16% | -10.2% |
| Q1 2018 | $10,364,000 | +19.7% | 348,000 | +29.4% | 0.18% | +18.0% |
| Q4 2017 | $8,656,000 | +37.5% | 269,000 | +48.6% | 0.15% | +36.4% |
| Q3 2017 | $6,295,000 | – | 181,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |